Multiple Manufacturers


ASP | WAC | AWP at the HCPCS Unit


Multiple Manufacturers

Bicnu HCPCS:


HCPCS Code Descriptor:

Injection, carmustine, 100 mg


J Code

Bicnu NDCs:

00781-3474-32, 70710-1525-09, 43598-0628-57, 23155-0790-41, 70121-1482-02, 71288-0126-90, 54879-0036-64, 70860-0223-61, 23155-0261-41, 23155-0649-41, 62332-0659-02

Primary Type:


Generic/Specialty Status:


Package Type:


Route of Administration:


Bicnu CPT Codes:

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

We have identified listing errors with the following NDCs:

62332-0659-02, 23155-0261-41, 54879-0036-64, 71288-0126-90, 70710-1525-09, 70860-0223-61, 43598-0628-57

About Bicnu:

BICNU is a medication manufactured by multiple manufacturers and aligned to the J Code: J9050. BICNU is administered via the intravenous route of administration.

BICNU is an alkylating agent that is used to treat various types of cancer. This medication works by manipulating the DNA of cancer cells in such a way that slows and stops the growth of cancer cells. BICNU is a generic medication that is manufactured by Heritage Pharmaceuticals, Sandoz, Amneal Biosciences and many other pharmaceutical manufacturing companies. This drug is currently aligned to the HCPCS code J9050 and has been since January 1st, 2009.


J9050 Added Date:

January 1, 1984

J9050 Effective Date:

January 1, 2009

J9050 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Bicnu billing and coding information.
Our team did not identify a source for Bicnu patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for BICNU
Our team has not yet identified a source of side effects information for BICNU. Please check back in a few weeks.